Cencora, Inc. (COR)
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Latest Price
$311.34
TTM P/E
23.86
Normalized P/E
32.57
Div Yield
0.74%
Book Value
17.46
P/B Ratio
17.83
Valuation metrics
adjust assumptions →EPS: $7.96
Book value / share: $7.78
Formula: √(22.5 × EPS × BVPS)
Graham Number
$37.32
88% downside
Norm. op. income: $2.3B (median of 7yr)
Tax rate: 24%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$74.17
76% downside
Base FCF: $3.0B (median of recent 5yr)
Growth: 3%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$209.98
33% downside
EPS: $7.96
Target P/E: 33×
Formula: EPS × P/E
P/E Fair Value
$262.68
16% downside
Institutional Ownership
76.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 19.94M | $6.26B | 10.25% | -342.4K | 2026-03-31 |
| STATE STREET CORP | 9.19M | $2.89B | 4.72% | -115.0K | 2026-03-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 7.32M | $2.30B | 3.76% | +330.9K | 2026-03-31 |
| FMR LLC | 6.69M | $2.10B | 3.44% | +1.23M | 2026-03-31 |
| T. Rowe Price Investment Management, Inc. | 6.29M | $1.98B | 3.24% | +1.63M | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 5.57M | $1.75B | 2.86% | +106.6K | 2026-03-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 4.55M | $1.43B | 2.34% | +12.6K | 2026-03-31 |
| MORGAN STANLEY | 4.53M | $1.42B | 2.33% | +1.61M | 2026-03-31 |
| Boston Partners | 4.48M | $1.41B | 2.30% | +286.3K | 2026-03-31 |
| BANK OF AMERICA CORP /DE/ | 4.14M | $1.30B | 2.13% | +267.3K | 2026-03-31 |